Analyst Consensus ?
ConsensusHold42 ratings
Bullish1638.1%
Neutral2252.4%
Bearish49.5%
FN2 Earnings Intelligence
The Progressive Corporation (PGR) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 12, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Aug 27, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | Aug 20, 2026 |
| Keefe, Bruyette & Woods | Outperform | Market Perform | Upgrade | Aug 20, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Aug 17, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 4, 2026 |
| Morgan Stanley | Equal Weight | Underweight | Upgrade | Jul 24, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 16, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 16, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 16, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jul 9, 2026 |
| HSBC | Hold | Hold | Maintain | Jul 6, 2026 |
| Jefferies | Hold | Hold | Maintain | Mar 24, 2026 |
| Citigroup | Buy | Buy | Maintain | Feb 4, 2026 |
| Barclays | Overweight | Equal Weight | Upgrade | Jan 8, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 28, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Oct 17, 2025 |
| Roth MKM | Buy | Buy | Maintain | Feb 25, 2025 |
| TD Cowen | Hold | Hold | Maintain | Nov 8, 2024 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 15, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Aug 18, 2022 |
| MKM Partners | Buy | Buy | Maintain | Jul 18, 2022 |
| Edward Jones | Hold | Buy | Downgrade | Feb 9, 2022 |
| Wolfe Research | Underperform | Underperform | Maintain | Aug 17, 2021 |
| Deutsche Bank | Buy | Buy | Maintain | Feb 1, 2021 |
| B. Riley Securities | Neutral | Buy | Downgrade | Mar 11, 2020 |
| B. Riley FBR | Neutral | Buy | Downgrade | Mar 11, 2020 |
| B. Riley | Neutral | Buy | Downgrade | Mar 11, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Dec 6, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Dec 6, 2019 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | May 17, 2018 |
| Sandler O'Neill | Buy | Hold | Upgrade | Mar 21, 2017 |
| Bank of America | Buy | Neutral | Upgrade | Mar 20, 2017 |
| Bernstein | Market Perform | Outperform | Downgrade | Jan 19, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Sep 21, 2015 |
| JMP Securities | Outperform | Market Outperform | Maintain | Sep 16, 2015 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Jan 7, 2015 |
| Janney Capital | Buy | Neutral | Upgrade | Jan 7, 2015 |
| Evercore Partners | Equal Weight | Underweight | Upgrade | Jul 15, 2014 |
| William Blair | Outperform | Underperform | Upgrade | Mar 21, 2014 |
| Nomura | Reduce | Reduce | Maintain | Dec 12, 2013 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Mar 14, 2013 |
| Macquarie | Underperform | Neutral | Downgrade | Jan 17, 2013 |
Upside is calculated against the persisted current price $217.62. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Brian Meredith | $234 | $222.51 | +7.5% | Aug 27, 2026 |
| Roth Capital | Harry Fong | $245 | $217.27 | +12.6% | Aug 20, 2026 |
| Goldman Sachs | Alex Scott | $230 | $216.15 | +5.7% | Aug 19, 2026 |
| Jefferies | Andrew Andersen | $228 | $216.03 | +4.8% | Aug 19, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $200 | $207.7 | -8.1% | Aug 17, 2026 |
| Mizuho Securities | Analyst unavailable | $236 | $210.75 | +8.4% | Aug 5, 2026 |
| Morgan Stanley | Bob Huang | $210 | $207.07 | -3.5% | Jul 24, 2026 |
| BMO Capital | Analyst unavailable | $205 | $205.22 | -5.8% | Jul 16, 2026 |
| Wells Fargo | Elyse Greenspan | $198 | $205.22 | -9.0% | Jul 16, 2026 |
| Evercore ISI | Analyst unavailable | $240 | $229.64 | +10.3% | Jul 10, 2026 |
| Mizuho Securities | Analyst unavailable | $243 | $232.9 | +11.7% | Jul 9, 2026 |
| HSBC | Vikram Gandhi | $221 | $232.22 | +1.6% | Jul 6, 2026 |
| UBS | Analyst unavailable | $230 | $220.17 | +5.7% | Jun 30, 2026 |
| Wells Fargo | Analyst unavailable | $205 | $224.34 | -5.8% | Jun 29, 2026 |
| Wells Fargo | Elyse Greenspan | $219 | $204.42 | +0.6% | Jun 18, 2026 |
| RBC Capital | Analyst unavailable | $208 | $197.89 | -4.4% | May 22, 2026 |
| BMO Capital | Michael Zaremski | $220 | $201.92 | +1.1% | May 20, 2026 |
| BMO Capital | Analyst unavailable | $221 | $201.23 | +1.6% | Apr 16, 2026 |
| Wells Fargo | Elyse Greenspan | $218 | $201.23 | +0.2% | Apr 16, 2026 |
| Barclays | Alex Scott | $247 | $202.79 | +13.5% | Mar 18, 2026 |
| BMO Capital | Michael Zaremski | $208 | $203.21 | -4.4% | Mar 11, 2026 |
| Piper Sandler | Paul Newsome | $259 | $212.8 | +19.0% | Mar 2, 2026 |
| Goldman Sachs | Alex Scott | $225 | $203.69 | +3.4% | Feb 23, 2026 |
| UBS | Brian Meredith | $218 | $203.62 | +0.2% | Feb 23, 2026 |
| Evercore ISI | Analyst unavailable | $230 | $203.52 | +5.7% | Feb 19, 2026 |
| Roth Capital | Analyst unavailable | $235 | $203.32 | +8.0% | Feb 19, 2026 |
| Wells Fargo | Analyst unavailable | $214 | $203.28 | -1.7% | Feb 19, 2026 |
| Jefferies | Analyst unavailable | $216 | $209.29 | -0.7% | Feb 11, 2026 |
| UBS | Analyst unavailable | $226 | $208 | +3.9% | Feb 2, 2026 |
| BMO Capital | Analyst unavailable | $232 | $208.88 | +6.6% | Jan 29, 2026 |
| HSBC | Analyst unavailable | $224 | $201.97 | +2.9% | Jan 16, 2026 |
| BMO Capital | Michael Zaremski | $239 | $205.5 | +9.8% | Jan 15, 2026 |
| Mizuho Securities | Yaron Kinar | $240 | $205.83 | +10.3% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $240 | $216.5 | +10.3% | Jan 13, 2026 |
| Barclays | Alex Scott | $265 | $209.1 | +21.8% | Jan 8, 2026 |
| Goldman Sachs | Analyst unavailable | $227 | $209.1 | +4.3% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $237 | $213.98 | +8.9% | Jan 7, 2026 |
| Wells Fargo | Elyse Greenspan | $242 | $224.86 | +11.2% | Dec 19, 2025 |
| BMO Capital | Analyst unavailable | $253 | $227.27 | +16.3% | Dec 18, 2025 |
| Mizuho Securities | Analyst unavailable | $242 | $236.18 | +11.2% | Dec 15, 2025 |
| BMO Capital | Analyst unavailable | $256 | $223.16 | +17.6% | Dec 9, 2025 |
| BMO Capital | Michael Zaremski | $260 | $226 | +19.5% | Nov 21, 2025 |
| Wells Fargo | Analyst unavailable | $247 | $222.93 | +13.5% | Nov 20, 2025 |
| HSBC | Vikram Gandhi | $259 | $225.14 | +19.0% | Nov 17, 2025 |
| Jefferies | Andrew Andersen | $232 | $223.15 | +6.6% | Nov 14, 2025 |
| Goldman Sachs | Alex Scott | $245 | $216.64 | +12.6% | Oct 27, 2025 |
| Barclays | Alex Scott | $257 | $225.61 | +18.1% | Oct 20, 2025 |
| Morgan Stanley | Bob Huang | $214 | $225.61 | -1.7% | Oct 20, 2025 |
| Raymond James | Analyst unavailable | $265 | $223.34 | +21.8% | Oct 17, 2025 |
| BMO Capital | Analyst unavailable | $247 | $226.5 | +13.5% | Oct 16, 2025 |
| Wells Fargo | Elyse Greenspan | $246 | $226.5 | +13.0% | Oct 16, 2025 |
| UBS | Analyst unavailable | $261 | $244.82 | +19.9% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $271 | $243.89 | +24.5% | Oct 8, 2025 |
| Evercore ISI | Analyst unavailable | $273 | $247.51 | +25.4% | Oct 1, 2025 |
| BMO Capital | Analyst unavailable | $252 | $243.49 | +15.8% | Sep 18, 2025 |
| Wells Fargo | Analyst unavailable | $265 | $243.49 | +21.8% | Sep 18, 2025 |
| BMO Capital | Analyst unavailable | $250 | $243.61 | +14.9% | Sep 17, 2025 |
| Morgan Stanley | Analyst unavailable | $267 | $249.21 | +22.7% | Aug 22, 2025 |
| Morgan Stanley | Bob Huang | $265 | $246.51 | +21.8% | Aug 11, 2025 |
| Morgan Stanley | Bob Huang | $330 | $288.24 | +51.6% | May 19, 2025 |
| Wells Fargo | Elyse Greenspan | $328 | $283.66 | +50.7% | May 7, 2025 |
| Goldman Sachs | Alex Scott | $294 | $246.74 | +35.1% | Nov 6, 2024 |
| BMO Capital | Michael Zaremski | $273 | $241.48 | +25.4% | Nov 4, 2024 |
| Goldman Sachs | Alex Scott | $292 | $250.74 | +34.2% | Oct 21, 2024 |
| Morgan Stanley | Bob Huang | $310 | $251.34 | +42.5% | Oct 18, 2024 |
| CFRA | Catherine Seifert | $290 | $252.61 | +33.3% | Oct 16, 2024 |
| Wells Fargo | Elyse Greenspan | $297 | $251.6 | +36.5% | Oct 16, 2024 |
| Citigroup | Michael Ward | $257 | $255.36 | +18.1% | Oct 4, 2024 |
| Goldman Sachs | Alex Scott | $280 | $255.44 | +28.7% | Sep 17, 2024 |
| Morgan Stanley | Bob Huang | $300 | $255.46 | +37.9% | Sep 16, 2024 |
| Bank of America Securities | Joshua Shanker | $309 | $255.46 | +42.0% | Sep 15, 2024 |
| Morgan Stanley | Bob Huang | $260 | $255.46 | +19.5% | Sep 14, 2024 |
| Wells Fargo | Elyse Greenspan | $282 | $251.31 | +29.6% | Sep 10, 2024 |
| Barclays | Alex Scott | $267 | $253.91 | +22.7% | Sep 4, 2024 |
| Bank of America Securities | Joshua Shanker | $312 | $252.2 | +43.4% | Sep 3, 2024 |
| Piper Sandler | Paul Newsome | $252 | $234.34 | +15.8% | Aug 15, 2024 |
| Goldman Sachs | Alex Scott | $262 | $235.17 | +20.4% | Aug 15, 2024 |
| Evercore ISI | David Motemaden | $257 | $234.34 | +18.1% | Aug 14, 2024 |
| HSBC | Vikram Gandhi | $253 | $222.99 | +16.3% | Aug 12, 2024 |
| BMO Capital | Michael Zaremski | $237 | $214.05 | +8.9% | Aug 7, 2024 |
| Jefferies | Yaron Kinar | $257 | $210 | +18.1% | Jul 17, 2024 |
| Morgan Stanley | Bob Huang | $255 | $212.53 | +17.2% | Jun 10, 2024 |
| Wells Fargo | Elyse Greenspan | $243 | $209.22 | +11.7% | May 20, 2024 |
| BMO Capital | Michael Zaremski | $235 | $209.25 | +8.0% | May 16, 2024 |
| CFRA | Catherine Seifert | $235 | $206.59 | +8.0% | Apr 15, 2024 |
| BMO Capital | Michael Zaremski | $234 | $206.85 | +7.5% | Apr 15, 2024 |
| Jefferies | Yaron Kinar | $245 | $203.9 | +12.6% | Apr 12, 2024 |
| Piper Sandler | Paul Newsome | $240 | $202.26 | +10.3% | Apr 12, 2024 |
| Morgan Stanley | Bob Huang | $247 | $206.15 | +13.5% | Apr 11, 2024 |
| Evercore ISI | David Motemaden | $215 | $204.88 | -1.2% | Mar 15, 2024 |
| Morgan Stanley | Bob Huang | $227 | $196.01 | +4.3% | Mar 6, 2024 |
| Raymond James | Gregory Peters | $165 | $157.41 | -24.2% | Oct 16, 2023 |
| Citigroup | Analyst unavailable | $111 | $137.45 | -49.0% | Feb 1, 2023 |
| Barclays | Analyst unavailable | $109 | $126.58 | -49.9% | Dec 15, 2022 |
| Raymond James | Gregory Peters | $140 | $125.16 | -35.7% | Aug 29, 2022 |
| Morgan Stanley | Analyst unavailable | $130 | $127.48 | -40.3% | Aug 19, 2022 |
| Barclays | Analyst unavailable | $106 | $127.29 | -51.3% | Aug 18, 2022 |
| MKM Partners | Analyst unavailable | $135 | $113.16 | -38.0% | Jul 18, 2022 |
| Morgan Stanley | Analyst unavailable | $121 | $112.9 | -44.4% | Jul 18, 2022 |
| Credit Suisse | Andrew Kligerman | $124 | $106.95 | -43.0% | Apr 28, 2022 |
| Jefferies | Yaron Kinar | $90 | $108.72 | -58.6% | Jan 30, 2022 |
| Evercore ISI | David Motemaden | $118 | $109.75 | -45.8% | Jan 14, 2022 |
| MKM Partners | Harry Fong | $115 | $101.33 | -47.2% | Dec 16, 2021 |
| KBW | Meyer Shields | $92 | $101.33 | -57.7% | Dec 16, 2021 |
| Morgan Stanley | Michael Phillips CFA | $85 | $94.61 | -60.9% | Jun 7, 2021 |
| Piper Sandler | Nicole Miller Regan | $96 | $94.65 | -55.9% | Apr 12, 2021 |
Track every rating change on PGR the moment it posts. Free to start.
Start free